4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-19-011491
Chief Financial Officer gave up 821 shares (to pay taxes)
- Chief Financial Officer acquired 2,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hirsch Andrew Chief Financial Officer | 2019-02-16 | Option exercise | +2,750 | 13,195 | D: show line 1 in the form | ||
| Hirsch Andrew Chief Financial Officer | 2019-02-19 | Shares withheld for taxes | −821 | $58.03 | $47,643 | 12,374 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Hirsch Andrew Chief Financial Officer | 2019-02-16 | Option exercise · Restricted stock units | −2,750 | 5,500 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…